Literature DB >> 33902567

Falciparum but not vivax malaria increases the risk of hypertensive disorders of pregnancy in women followed prospectively from the first trimester.

Whitney E Harrington1,2,3, Kerryn A Moore4,5, Aung Myat Min1, Mary Ellen Gilder1, Nay Win Tun1, Moo Kho Paw1, Jacher Wiladphaingern1, Stephane Proux1, Kesinee Chotivanich6, Marcus J Rijken7,8, Nicholas J White9,10, François Nosten1,9, Rose McGready11,12.   

Abstract

BACKGROUND: Malaria and hypertensive disorders of pregnancy (HDoP) affect millions of pregnancies worldwide, particularly those of young, first-time mothers. Small case-control studies suggest a positive association between falciparum malaria and risk of pre-eclampsia but large prospective analyses are lacking.
METHODS: We characterized the relationship between malaria in pregnancy and the development of HDoP in a large, prospectively followed cohort. Pregnant women living along the Thailand-Myanmar border, an area of low seasonal malaria transmission, were followed at antenatal clinics between 1986 and 2016. The relationships between falciparum and vivax malaria during pregnancy and the odds of gestational hypertension, pre-eclampsia, or eclampsia were examined using logistic regression amongst all women and then stratified by gravidity.
RESULTS: There were 23,262 singleton pregnancies in women who presented during the first trimester and were followed fortnightly. Falciparum malaria was associated with gestational hypertension amongst multigravidae (adjusted odds ratio (AOR) 2.59, 95%CI 1.59-4.23), whereas amongst primigravidae, it was associated with the combined outcome of pre-eclampsia/eclampsia (AOR 2.61, 95%CI 1.01-6.79). In contrast, there was no association between vivax malaria and HDoP.
CONCLUSIONS: Falciparum but not vivax malaria during pregnancy is associated with hypertensive disorders of pregnancy.

Entities:  

Keywords:  Falciparum malaria; First trimester; Gestational hypertension; Pre-eclampsia; Vivax malaria

Year:  2021        PMID: 33902567     DOI: 10.1186/s12916-021-01960-3

Source DB:  PubMed          Journal:  BMC Med        ISSN: 1741-7015            Impact factor:   8.775


  27 in total

Review 1.  Establishment of the Human Uteroplacental Circulation: A Historical Perspective.

Authors:  Kenna Degner; Ronald R Magness; Dinesh M Shah
Journal:  Reprod Sci       Date:  2016-10-12       Impact factor: 3.060

2.  Gestational hypertension and preeclampsia: are they the same disease?

Authors:  Nir Melamed; Joel G Ray; Michelle Hladunewich; Brian Cox; John C Kingdom
Journal:  J Obstet Gynaecol Can       Date:  2014-07

3.  An analysis of malaria in pregnancy in Africa.

Authors:  B J Brabin
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

Review 4.  The sick placenta-the role of malaria.

Authors:  B J Brabin; C Romagosa; S Abdelgalil; C Menéndez; F H Verhoeff; R McGready; K A Fletcher; S Owens; U D'Alessandro; F Nosten; P R Fischer; J Ordi
Journal:  Placenta       Date:  2004-05       Impact factor: 3.481

Review 5.  Pre-eclampsia part 1: current understanding of its pathophysiology.

Authors:  Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Lami Yeo; Roberto Romero
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

6.  Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.

Authors:  R McGready; S J Lee; J Wiladphaingern; E A Ashley; M J Rijken; M Boel; J A Simpson; M K Paw; M Pimanpanarak; Oh Mu; P Singhasivanon; N J White; F H Nosten
Journal:  Lancet Infect Dis       Date:  2011-12-12       Impact factor: 25.071

Review 7.  Angiogenesis in the placenta: the role of reactive oxygen species signaling.

Authors:  Robyn D Pereira; Nicole E De Long; Ruijun C Wang; Fereshteh T Yazdi; Alison C Holloway; Sandeep Raha
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

8.  Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission.

Authors:  Kerryn A Moore; Julie A Simpson; Jacher Wiladphaingern; Aung Myat Min; Mupawjay Pimanpanarak; Moo Kho Paw; Jathee Raksuansak; Sasithon Pukrittayakamee; Freya J I Fowkes; Nicholas J White; François Nosten; Rose McGready
Journal:  BMC Med       Date:  2017-06-21       Impact factor: 8.775

9.  Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study.

Authors:  Jennifer B Griffin; Victor Lokomba; Sarah H Landis; John M Thorp; Amy H Herring; Antoinette K Tshefu; Stephen J Rogerson; Steven R Meshnick
Journal:  Malar J       Date:  2012-09-10       Impact factor: 2.979

10.  Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis.

Authors:  Ver Luanni Bilano; Erika Ota; Togoobaatar Ganchimeg; Rintaro Mori; João Paulo Souza
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

View more
  2 in total

1.  Quantification of the dynamics of antibody response to malaria to inform sero-surveillance in pregnant women.

Authors:  Julie A Simpson; Sophie G Zaloumis; A D V Tharkeshi T Dharmaratne; Saber Dini; Katherine O'Flaherty; David J Price; James Beeson; Rose McGready; Francois Nosten; Freya J I Fowkes
Journal:  Malar J       Date:  2022-03-05       Impact factor: 2.979

2.  High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes.

Authors:  Xin He; Danni Ding
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-15       Impact factor: 3.105

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.